-+ 0.00%
-+ 0.00%
-+ 0.00%

ACLARIS THERAPEUTICS RECEIVES FAST TRACK DESIGNATION FOR MODZATINIB (ATI-2138) FOR MODERATE TO SEVERE LICHEN PLANUS (LP)

Reuters·08/06/2026 20:35:00

Please log in to view news